路透9月24日 - 默克公司 MRK.N 周四表示,其研发的药物在一项针对患有某种影响眼底血管疾病的成人患者的中后期临床试验中,达到了主要研究目标。
路透9月24日 - 默克公司 MRK.N 周四表示,其研发的药物在一项针对患有某种影响眼底血管疾病的成人患者的中后期临床试验中,达到了主要研究目标。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.